S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NASDAQ:CPIX

Cumberland Pharmaceuticals (CPIX) Stock Forecast, Price & News

$2.00
-0.15 (-6.98%)
(As of 09/26/2023 ET)
Compare
Today's Range
$2.00
▼
$2.16
50-Day Range
$1.43
▼
$2.30
52-Week Range
$1.43
▼
$2.91
Volume
13,925 shs
Average Volume
21,708 shs
Market Capitalization
$28.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

CPIX stock logo

About Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

CPIX Price History

CPIX Stock News Headlines

September 26, 2023 | msn.com
Cumberland police say fatal stabbing suspect in custody, to release details at briefing
September 26, 2023 | msn.com
Two killed in Cumberland County crash
September 26, 2023 | Micro-Cap Stock Trader (Ad)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
September 26, 2023 | news.yahoo.com
Cumberland man arrested in alleged Mace attack, robbery
September 26, 2023 | msn.com
'That moment made me 110%': Why Desert Mountain DL Tony Cumberland committed to Oregon
September 26, 2023 | msn.com
Cumberland County DA's office asked to investigate alleged misappropriation of Gray town funds
September 26, 2023 | msn.com
Person killed in Tuesday morning shooting in Cumberland County.
September 26, 2023 | msn.com
Man breaks into change machines at Cumberland County laundromat
September 26, 2023 | Micro-Cap Stock Trader (Ad)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
September 26, 2023 | msn.com
151st Cumberland County Fair kicks off this week
September 25, 2023 | msn.com
Cumberland Valley Superintendent expected to take new position
September 25, 2023 | msn.com
Woman ID'd Following Crash In Cumberland County: Coroner
September 25, 2023 | msn.com
Cumberland Valley superintendent to leave for same job in eastern Pa. district
September 25, 2023 | msn.com
Rhode Island police investigating three separate homicides in Pawtucket, Central Falls, and Cumberland
September 25, 2023 | nj.com
See all homes sold in Cumberland County, Sept. 18 to Sept. 24
September 24, 2023 | msn.com
Police investigating fatal stabbing in Cumberland, R.I.
September 24, 2023 | msn.com
Police investigating stabbing in Cumberland
September 24, 2023 | msn.com
Man dies after stabbing in Cumberland. What we know.
September 24, 2023 | msn.com
Tony Cumberland, 2026 5-star defensive lineman, commits to Oregon Ducks
September 24, 2023 | msn.com
Crews respond to Cumberland County accident
September 24, 2023 | msn.com
Coroner called to Cumberland County accident
September 24, 2023 | msn.com
Police presence in Cumberland
September 24, 2023 | msn.com
Tony Cumberland, 5-Star Defensive Lineman, Commits to Oregon Ducks
September 23, 2023 | msn.com
Heavy police presence at Cumberland apartment building after stabbing
September 23, 2023 | msn.com
Police investigating stabbing in Cumberland, R.I.
September 23, 2023 | yahoo.com
You can now buy cognac inspired by Fayetteville's namesake at Cumberland County ABC stores
September 23, 2023 | msn.com
Two men arrested after shooting on Cumberland Avenue in Knoxville
See More Headlines
Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPIX Company Calendar

Last Earnings
8/08/2023
Today
9/26/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NASDAQ:CPIX
CUSIP
23077010
CIK
1087294
Web
www.cumberlandpharma.com
Phone
(615) 255-0068
Fax
615-255-0094
Employees
85
Year Founded
1999

Profitability

EPS (Most Recent Fiscal Year)
($0.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-5,570,000.00
Net Margins
-4.39%
Pretax Margin
-4.38%
Return on Equity
11.44%
Return on Assets
4.65%

Debt

Debt-to-Equity Ratio
0.36
Current Ratio
1.62
Quick Ratio
1.21

Sales & Book Value

Annual Sales
$42.01 million
Price / Sales
0.70
Cash Flow
$0.43 per share
Price / Cash Flow
4.78
Book Value
$2.45 per share
Price / Book
0.84

Miscellaneous

Outstanding Shares
14,370,000
Free Float
8,325,000
Market Cap
$29.46 million
Optionable
Optionable
Beta
0.30

Social Links

10 Best Stocks to Own in 2023 Cover
10 Best Stocks to Own in 2023

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. A. J. Kazimi MBA (Age 65)
    Founder, Chairman, Pres & CEO
    Comp: $897.5k
  • Mr. John Michael Hamm (Age 67)
    Chief Financial Officer
    Comp: $231.38k
  • Mr. James Lowrance Herman (Age 68)
    Exec. VP of National Accounts & Chief Compliance Officer
    Comp: $352.65k
  • Ms. Jean W. Marstiller (Age 73)
    Sr. VP of Admin. Services & Corp. Sec.
  • Mr. Chris T. Bitterman (Age 58)
    VP of Sales & Marketing
  • Mr. Adam S. Mostafa (Age 43)
    Managing Director
  • Mr. Todd M. Anthony (Age 62)
    VP of Organizational Devel.
  • Ms. Erin Smith Gull
    Sr. Corp. Relations Associate

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CPIX Stock - Frequently Asked Questions

How have CPIX shares performed in 2023?

Cumberland Pharmaceuticals' stock was trading at $2.25 at the beginning of the year. Since then, CPIX stock has decreased by 8.9% and is now trading at $2.05.
View the best growth stocks for 2023 here.

When is Cumberland Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our CPIX earnings forecast.

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced its earnings results on Tuesday, August, 8th. The specialty pharmaceutical company reported $0.15 EPS for the quarter. The specialty pharmaceutical company had revenue of $10.89 million for the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 11.44% and a negative net margin of 4.39%.

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?

9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cumberland Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS).

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

Who are Cumberland Pharmaceuticals' major shareholders?

Cumberland Pharmaceuticals' stock is owned by a number of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (3.88%), Dimensional Fund Advisors LP (3.51%), BlackRock Inc. (0.79%), B. Riley Wealth Advisors Inc. (0.62%) and Citadel Advisors LLC (0.00%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas.
View institutional ownership trends.

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cumberland Pharmaceuticals' stock price today?

One share of CPIX stock can currently be purchased for approximately $2.05.

How much money does Cumberland Pharmaceuticals make?

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a market capitalization of $29.46 million and generates $42.01 million in revenue each year. The specialty pharmaceutical company earns $-5,570,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis.

How can I contact Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The official website for the company is www.cumberlandpharma.com. The specialty pharmaceutical company can be reached via phone at (615) 255-0068, via email at investors@cumberlandpharma.com, or via fax at 615-255-0094.

This page (NASDAQ:CPIX) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -